AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.
Epistemonikos ID: a2a961b3f6d9fc395030bc85d9cdea275549bf5d
First added on: Feb 01, 2025